Glivec 100 mg hard capsules, Tasigna 150 mg hard capsules
CML1415 - Sustrenim
Approved small_molecule active
Quick answer
Glivec 100 mg hard capsules, Tasigna 150 mg hard capsules for Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) is a Approved program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active